Literature DB >> 2793399

Persistent HIV-2 infection of rhesus macaque, baboon, and mangabeys.

I Nicol1, G Flamminio-Zola, P Dubouch, J Bernard, R Snart, R Jouffre, B Reveil, M Fouchard, I Desportes, P Nara.   

Abstract

Six monkeys of three different species (mangabey, macaque and baboon) were infected with human immunodeficiency type 2 (HIV-2) NIH-DZ using intraperitoneal or intravenous injections of cell-free HIV-2 or autologous HIV-2-infected cells with no prior immunostimulation. Viral expression was demonstrated by reverse transcriptase activity in cells after coculture with human peripheral blood lymphocytes or by electron microscopy. Serum was analyzed by western blot, enzyme-linked immunosorbent assay (detection of antigen and antibody), and neutralization assay carried out using immunofluorescence techniques. The 6 inoculated animals seroconverted during the 1st month after inoculation and remained persistently infected after 6-11 months. We also observed proviral DNA by genomic analysis in the six tested samples. No sign of immunodeficiency disease has been observed so far. The data suggest that HIV-2 infection of nonhuman primates provides an acceptable animal model to investigate vaccination or specific immunotherapeutic procedures.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2793399     DOI: 10.1159/000150101

Source DB:  PubMed          Journal:  Intervirology        ISSN: 0300-5526            Impact factor:   1.763


  8 in total

1.  Isolation from African Sykes' monkeys (Cercopithecus mitis) of a lentivirus related to human and simian immunodeficiency viruses.

Authors:  P Emau; H M McClure; M Isahakia; J G Else; P N Fultz
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

2.  Rapid CD4(+) T-cell loss induced by human immunodeficiency virus type 1(NC) in uninfected and previously infected chimpanzees.

Authors:  F J Novembre; J de Rosayro; S Nidtha; S P O'Neil; T R Gibson; T Evans-Strickfaden; C E Hart; H M McClure
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

3.  Persistent infection of rhesus macaques with a molecular clone of human immunodeficiency virus type 2: evidence of minimal genetic drift and low pathogenetic effects.

Authors:  G Franchini; P Markham; E Gard; K Fargnoli; S Keubaruwa; L Jagodzinski; M Robert-Guroff; P Lusso; G Ford; F Wong-Staal
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

4.  A single amino acid substitution in hypervariable region 5 of the envelope protein of feline immunodeficiency virus allows escape from virus neutralization.

Authors:  K H Siebelink; G F Rimmelzwaan; M L Bosch; R H Meloen; A D Osterhaus
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

5.  In vivo genetic variability of the human immunodeficiency virus type 2 V3 region.

Authors:  E Boeri; A Giri; F Lillo; G Ferrari; O E Varnier; A Ferro; S Sabbatani; W C Saxinger; G Franchini
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

6.  Serological, biological, and molecular characterization of New Zealand white rabbits infected by intraperitoneal inoculation with cell-free human immunodeficiency virus.

Authors:  S Reina; P Markham; E Gard; F Rayed; M Reitz; R C Gallo; O E Varnier
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

7.  Evolution of the human immunodeficiency virus type 2 envelope gene in preimmunized and persistently infected rhesus macaques.

Authors:  M H Bäyon-Auboyer; F D Boussin; G Vogt; R Le Grand; B Vaslin; I Nicol-Jourdain; D Dormont
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

8.  Cross-neutralization of human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus isolates.

Authors:  M Robert-Guroff; K Aldrich; R Muldoon; T L Stern; G P Bansal; T J Matthews; P D Markham; R C Gallo; G Franchini
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.